PLAGL1

PLAGL1
Identifiers
Aliases	PLAGL1, LOT1, ZAC, ZAC1, PLAG1 like zinc finger 1
External IDs	OMIM: 603044; MGI: 1100874; HomoloGene: 31401; GeneCards: PLAGL1; OMA:PLAGL1 - orthologs
Gene location (Human) Chr. Chromosome 6 (human) Band 6q24.2 Start 143,940,300 bp End 144,064,599 bp
Gene location (Mouse) Chr. Chromosome 10 (mouse) Band 10 A2|10 4.72 cM Start 13,060,504 bp End 13,131,694 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in skin of hip placenta right adrenal cortex tibia cartilage tissue pituitary gland synovial joint human penis Descending thoracic aorta skin of thigh Top expressed in efferent ductule dermis human fetus Gonadal ridge atrium internal carotid artery median eminence umbilical cord left lung lobe abdominal wall More reference expression data BioGPS More reference expression data
Gene ontology Molecular function DNA-binding transcription activator activity, RNA polymerase II-specific nucleic acid binding metal ion binding DNA binding RNA polymerase II transcription regulatory region sequence-specific DNA binding DNA-binding transcription factor activity, RNA polymerase II-specific Cellular component Golgi apparatus intracellular membrane-bounded organelle nucleus nucleoplasm nuclear body Biological process cell differentiation regulation of transcription, DNA-templated positive regulation of transcription by RNA polymerase II transcription, DNA-templated apoptotic process DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest transcription by RNA polymerase II regulation of transcription by RNA polymerase II Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 5325 22634 Ensembl ENSG00000118495 ENSMUSG00000019817 UniProt Q9UM63 n/a RefSeq (mRNA) NM_006718 NM_001080951 NM_001080952 NM_001080953 NM_001080954 NM_001080955 NM_001080956 NM_001289037 NM_001289038 NM_001289039 NM_001289040 NM_001289041 NM_001289042 NM_001289043 NM_001289044 NM_001289045 NM_001289046 NM_001289047 NM_001289048 NM_001289049 NM_002656 NM_001317156 NM_001317157 NM_001317158 NM_001317159 NM_001317160 NM_001317161 NM_001317162 NM_009538 RefSeq (protein) NP_001074420 NP_001074421 NP_001074422 NP_001074423 NP_001074424 NP_001074425 NP_001275966 NP_001275967 NP_001275968 NP_001275969 NP_001275970 NP_001275971 NP_001275972 NP_001275973 NP_001275974 NP_001275975 NP_001275976 NP_001275977 NP_001275978 NP_001304085 NP_001304086 NP_001304087 NP_001304088 NP_001304089 NP_001304090 NP_001304091 NP_006709 n/a Location (UCSC) Chr 6: 143.94 – 144.06 Mb Chr 10: 13.06 – 13.13 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Zinc finger protein PLAGL1 is a protein that in humans is encoded by the PLAGL1 gene.

Function

This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activity. This gene has been shown to exhibit antiproliferative activities and is a tumor suppressor gene candidate. Many transcript variants encoding two different isoforms have been found for this gene.

Interactions

PLAGL1 has been shown to interact with P53.

Further reading

• Vernon M (2005). "Fifty years of research on the intelligence of deaf and hard-of-hearing children: a review of literature and discussion of implications". J Deaf Stud Deaf Educ. 10 (3): 225–31. doi:10.1093/deafed/eni024. PMID 15888725.
• Abdollahi A, Roberts D, Godwin AK, Schultz DC, Sonoda G, Testa JR, Hamilton TC (1997). "Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors". Oncogene. 14 (16): 1973–9. doi:10.1038/sj.onc.1201034. PMID 9150364. S2CID 24314159.
• Abdollahi A, Godwin AK, Miller PD, Getts LA, Schultz DC, Taguchi T, Testa JR, Hamilton TC (1997). "Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells". Cancer Res. 57 (10): 2029–34. PMID 9158001.
• Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, Bockaert J, Journot L (1997). "Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain". EMBO J. 16 (10): 2814–25. doi:10.1093/emboj/16.10.2814. PMC 1169890. PMID 9184226.
• Abdollahi A, Bao R, Hamilton TC (1999). "LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein". Oncogene. 18 (47): 6477–87. doi:10.1038/sj.onc.1203067. PMID 10597250. S2CID 25450943.
• Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT, Hayashizaki Y (2000). "The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes". Hum. Mol. Genet. 9 (3): 453–60. doi:10.1093/hmg/9.3.453. PMID 10655556.
• Bilanges B, Varrault A, Mazumdar A, Pantaloni C, Hoffmann A, Bockaert J, Spengler D, Journot L (2001). "Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities". Oncogene. 20 (10): 1246–53. doi:10.1038/sj.onc.1204237. PMID 11313869.
• Huang SM, Schönthal AH, Stallcup MR (2001). "Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1". Oncogene. 20 (17): 2134–43. doi:10.1038/sj.onc.1204298. PMID 11360197. S2CID 21331603.
• Mackay DJ, Coupe AM, Shield JP, Storr JN, Temple IK, Robinson DO (2002). "Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus". Hum. Genet. 110 (2): 139–44. doi:10.1007/s00439-001-0671-5. PMID 11935319. S2CID 22321580.
• Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC (2003). "LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer". J. Biol. Chem. 278 (8): 6041–9. doi:10.1074/jbc.M210361200. PMID 12473647.
• Hoffmann A, Ciani E, Boeckardt J, Holsboer F, Journot L, Spengler D (2003). "Transcriptional activities of the zinc finger protein Zac are differentially controlled by DNA binding". Mol. Cell. Biol. 23 (3): 988–1003. doi:10.1128/MCB.23.3.988-1003.2003. PMC 140694. PMID 12529403.
• Colland F, Jacq X, Trouplin V, Mougin C, Groizeleau C, Hamburger A, Meil A, Wojcik J, Legrain P, Gauthier JM (2004). "Functional proteomics mapping of a human signaling pathway". Genome Res. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMC 442148. PMID 15231748.
• Ma D, Shield JP, Dean W, Leclerc I, Knauf C, Burcelin R, Rutter GA, Kelsey G (2004). "Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM". J. Clin. Invest. 114 (3): 339–48. doi:10.1172/JCI19876. PMC 484972. PMID 15286800.
• Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A (2004). "Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer". Gynecol. Oncol. 95 (3): 449–55. doi:10.1016/j.ygyno.2004.08.051. PMID 15581945.
• Mitchell J, Punthakee Z, Lo B, Bernard C, Chong K, Newman C, Cartier L, Desilets V, Cutz E, Hansen IL, Riley P, Polychronakos C (2004). "Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome". Diabetologia. 47 (12): 2160–7. doi:10.1007/s00125-004-1576-3. PMID 15592663.